A detailed history of J.W. Cole Advisors, Inc. transactions in Silverback Therapeutics, Inc. stock. As of the latest transaction made, J.W. Cole Advisors, Inc. holds 20,520 shares of SBTX stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,520
Previous 15,400 33.25%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
N/A
5,120 Added 33.25%
20,520 $0
Q2 2024

Aug 08, 2024

BUY
N/A
1,500 Added 10.79%
15,400 $0
Q1 2024

Apr 30, 2024

BUY
N/A
13,900 New
13,900 $0

Others Institutions Holding SBTX

About Silverback Therapeutics, Inc.


  • Ticker SBTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,473,800
  • Description
  • Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...
More about SBTX
Track This Portfolio

Track J.W. Cole Advisors, Inc. Portfolio

Follow J.W. Cole Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J.W. Cole Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on J.W. Cole Advisors, Inc. with notifications on news.